$1.49
0[0.00%]
At close: May 6
$1.49
0[0.00%]
After Hours: 5:02PM EDT
IO Biotech
(NASDAQ:IOBT)Latest News for IO Biotech Stock (NASDAQ:IOBT)
IO Biotech Stock (NASDAQ: IOBT)
Categories: All
Tuesday, April 09, 2024
Wednesday, March 06, 2024
Tuesday, March 05, 2024
Monday, January 22, 2024
Thursday, December 21, 2023
Monday, November 27, 2023
Monday, November 13, 2023
Friday, November 10, 2023
Tuesday, October 24, 2023
Monday, October 23, 2023
Tuesday, October 03, 2023
Thursday, September 28, 2023
- Expert Ratings for IO BiotechBenzinga Insights - Sep 28, 2023, 11:00AM
- Benzinga's Top Ratings Upgrades, Downgrades For September 28, 2023Benzinga Insights - Sep 28, 2023, 11:00AM
- Piper Sandler Initiates Coverage On IO Biotech with Overweight Rating, Announces Price Target of $10Benzinga Newsdesk - Sep 28, 2023, 7:17AM
Wednesday, September 13, 2023
Tuesday, September 12, 2023
Tuesday, August 15, 2023
Friday, August 11, 2023
Thursday, August 10, 2023
Friday, July 28, 2023
Thursday, July 20, 2023
Thursday, June 15, 2023
- 12 Health Care Stocks Moving In Thursday's Intraday SessionBenzinga Insights - Jun 15, 2023, 1:31PM
- Why John Wiley & Sons Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Thursday's Mid-Day SessionLisa Levin - Jun 15, 2023, 1:12PM
- Watching IO Biotech, Nkarta Shares; Traders Circulate Article Titled '2 "Strong Buy" Penny Stocks That Could Rally Over 300%'Benzinga Newsdesk - Jun 15, 2023, 10:03AM
Wednesday, June 14, 2023
- 12 Health Care Stocks Moving In Wednesday's Intraday SessionBenzinga Insights - Jun 14, 2023, 1:32PM
- Stocks That Hit 52-Week Lows On WednesdayBenzinga Insights - Jun 14, 2023, 1:13PM
- Why MIND Technology Shares Are Trading Lower By Over 20%? Here Are Other Stocks Moving In Wednesday's Mid-Day SessionLisa Levin - Jun 14, 2023, 1:12PM
- Why Are IO Biotech Shares Trading Lower TodayVandana Singh - Jun 14, 2023, 10:42AM
- IO Biotech shares are trading lower after the company increased the enrolled patients in Phase 3 trial to 380, potentially accelerating the time to reach the primary end point of progression free survivalBenzinga Newsdesk - Jun 14, 2023, 9:58AM
- 12 Health Care Stocks Moving In Wednesday's Pre-Market SessionBenzinga Insights - Jun 14, 2023, 9:07AM
- IO Biotech Announces Achievement Of Significant Phase 3 Clinical Trial Recruitment MilestoneHappy Mohamed - Jun 14, 2023, 8:01AM